Lisdexamfetamine, marketed as Vyvanse, is a prescription medication approved for attention deficit hyperactivity disorder in youngsters and adults . In Canada, its distribution is strictly regulated by Health Canada. This resource seeks to present clear information on its uses , potential side ef